C. Hicking

Type de document

Co-auteur

M. Picard

L.B. Nabors

M.E. Hegi

V. Zagonel

W. Wick

M. Weller

R. Tarnawski

R. Stupp

J. Straub

M. Salacz

E. Rushing

P. Roth

D.A. Reardon

J.R. Perry

J. Perry

H Nam do

H. Moch

T. Mikkelsen

M. Mazurkiewicz

B. Lhermitte

H. Leske

Y.K. Hong

D. Grujicic

T. Gorlia

S.L. Goodman

K.L. Fink

R. Depenni

P. Bady

L. Ashby

Date

Source

Serveur académique Lausannois (2)

Mot-clé

puits (2) thérapie (2) survie (2) Treatment (2) Therapeutics (2) Survival (2) Patients (2) Patients (2) nucleus (2) norme (1) serpent (1) sécurité (1) pharmacocinétique (1) association (1) danger (1) gène (1) firme (1) dose (1) ADN (1) adulte (1) biomarqueur (1) procès (1) cancer (1) taux (1) jeune (1) Control (1) Cancer (1) Methods (1) Integrins (1) Neovascularization (1)

Documents écrit par C. Hicking (2) | parle de C. Hicking (0)

Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome.

M. Weller et al. (22 mars 2016)

Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.

L.B. Nabors et al. (2015)